100 results
S-8 POS
CMRA
Comera Life Sciences Holdings, Inc.
26 Feb 24
Registration of securities for employees (post-effective amendment)
4:37pm
to an employee of the Registrant to induce the employee to accept employment with the Registrant; and
Registration Statement No. 333-274485, filed
S-8 POS
CMRA
Comera Life Sciences Holdings, Inc.
26 Feb 24
Registration of securities for employees (post-effective amendment)
4:36pm
to an employee of the Registrant to induce the employee to accept employment with the Registrant; and
Registration Statement No. 333-274485, filed
S-8 POS
CMRA
Comera Life Sciences Holdings, Inc.
26 Feb 24
Registration of securities for employees (post-effective amendment)
4:35pm
to an employee of the Registrant to induce the employee to accept employment with the Registrant; and
Registration Statement No. 333-274485, filed
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:20pm
to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations … capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under
424B3
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:20pm
for a Registration Statement on Form S-8 in connection with any employee benefit plan, unless such restriction is waived by Purchasers representing a majority
424B3
EX-4.1
vrhdrpr1qgv
29 Dec 23
Prospectus supplement
5:20pm
424B3
EX-4.1
zh7vc2w2f 3yyv3qf
29 Dec 23
Prospectus supplement
5:17pm
424B3
ktqqwozt1n87r3k iq
29 Dec 23
Prospectus supplement
5:17pm
424B3
EX-10.1
5n7wb29wgtn8xsj1ad
29 Dec 23
Prospectus supplement
5:17pm
424B3
EX-4.1
fhthqn7nabc19zu2
29 Dec 23
Prospectus supplement
5:15pm
424B3
EX-10.1
h4yex5qzmp4vqoyws5
29 Dec 23
Prospectus supplement
5:15pm
424B3
qi44v
29 Dec 23
Prospectus supplement
5:15pm
8-K
gp3p3zpl5wbcd8sl9v
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
3c8a1qv044kc
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
t0f2aa8a
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
424B3
r1lon
9 Nov 23
Prospectus supplement
4:36pm
424B3
f36sy0w510 qqboop
9 Nov 23
Prospectus supplement
4:35pm
424B3
9hzynmfq 9rj8
9 Nov 23
Prospectus supplement
4:33pm
8-K
EX-99.1
a5sy5j06x2iwb2u3l5k
9 Nov 23
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
4:31pm